Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) are difficult to develop. In a new review article in Cell Host & Microbe, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the N
Washington [US], April 8 (ANI): US' National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.
Washington D.C. [USA], Mar 21 (ANI): United States President Donald Trump has called for an anti-malaria drug to be used to treat the coronavirus, despite being cautioned by his health expert Dr. Anthony S. Fauci saying that evidence for its effectiveness was so far "anecdotal".